Lantheus Quarterly Balance Sheet
NASDAQ: LNTHHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Lantheus financial position
As of Jun 30, 2026, Lantheus reported total assets of $2.41 billion, up 14.1% from a year earlier against total liabilities of $1.10 billion. Shareholders' equity stood at $1.31 billion, or 54.3% of assets. The company held $593.3 million in cash and equivalents against $571.1 million of debt, a net cash position of $22.2 million.
The current ratio (current assets divided by current liabilities) was 3.06, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.44.
Summary generated from market data by MetaCap's automated system. Methodology
Lantheus balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 593.30M | 498.58M | 359.12M | 382.01M | 695.57M | 938.53M | 912.81M | 866.39M | 757.02M | 718.28M | 713.66M | 614.13M |
| Receivables | 352.89M | 355.67M | 358.64M | 351.38M | 336.58M | 348.75M | 321.26M | 329.34M | 372.29M | 337.39M | 284.29M | 259.20M |
| Inventory | 57.55M | 61.34M | 64.67M | 62.04M | 62.16M | 69.13M | 68.03M | 70.83M | 70.52M | 69.76M | 64.03M | 56.46M |
| Total Current Assets | 1.03B | 942.29M | 899.96M | 925.09M | 1.20B | 1.42B | 1.33B | 1.30B | 1.23B | 1.15B | 1.09B | 948.43M |
| Property, Plant & Equipment | 153.27M | 157.56M | 163.69M | 164.07M | 157.73M | 180.78M | 176.80M | 169.51M | 158.16M | 150.09M | 146.70M | 140.29M |
| Goodwill | 239.05M | 239.40M | 239.52M | 240.33M | 176.87M | 61.19M | 61.19M | 61.19M | 61.19M | 61.19M | 61.19M | 61.19M |
| Intangible Assets | 689.34M | 706.06M | 722.78M | 739.26M | 359.95M | 153.75M | 161.76M | 173.61M | 172.24M | 142.05M | 151.99M | 163.29M |
| Total Assets | 2.41B | 2.35B | 2.23B | 2.28B | 2.12B | 2.06B | 1.98B | 2.05B | 1.94B | 1.83B | 1.65B | 1.52B |
| Accounts Payable | 48.11M | 45.88M | 42.91M | 66.30M | 40.89M | 44.87M | 34.56M | 44.91M | 49.77M | 37.52M | 41.19M | 37.08M |
| Short-Term Debt | 697.00K | 803.00K | 738.00K | 871.00K | 796.00K | 747.00K | 974.00K | 564.71M | 868.00K | 734.00K | 823.00K | 703.00K |
| Total Current Liabilities | 335.68M | 333.17M | 333.42M | 346.84M | 280.13M | 248.00M | 240.53M | 784.08M | 263.29M | 237.20M | 187.35M | 176.60M |
| Long-Term Debt | 570.35M | 569.60M | 568.68M | 567.94M | 566.85M | 566.10M | 565.28M | 613.00K | 563.19M | 562.47M | 561.67M | 560.58M |
| Total Liabilities | 1.10B | 1.13B | 1.14B | 1.16B | 949.29M | 891.03M | 892.33M | 869.92M | 913.15M | 885.79M | 835.26M | 822.85M |
| Shareholders' Equity | 1.31B | 1.21B | 1.09B | 1.12B | 1.17B | 1.16B | 1.09B | 1.18B | 1.03B | 945.54M | 815.89M | 698.76M |
| Retained Earnings | 872.95M | 797.92M | 679.50M | 625.42M | 597.64M | 518.89M | 445.94M | 457.74M | 326.64M | 264.57M | 133.50M | 30.12M |
| Total Debt | 571.05M | 570.41M | 569.42M | 568.81M | 567.64M | 566.85M | 566.25M | 565.33M | 564.06M | 563.20M | 562.49M | 561.28M |
| Net Cash (Debt) | 22.25M | -71.83M | -210.29M | -186.80M | 127.93M | 371.69M | 346.56M | 301.06M | 192.96M | 155.08M | 151.16M | 52.85M |
| Shares Outstanding | 65.27M | 65.07M | 64.59M | 71.77M | 71.70M | 71.61M | 68.45M | 70.85M | 70.75M | 70.64M | 69.86M | 69.81M |
This table shows 12 quarterly periods of Lantheus's balance sheet, from Q2 2026 back to Q3 2023, across 18 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow LNTH's reporting calendar. What is a balance sheet?